A case of late-onset sustained ventricular tachycardia following deployment of Amplatzer-type perimembranous VSD occluder

Catheter Cardiovasc Interv. 2014 Feb;83(2):256-60. doi: 10.1002/ccd.24627. Epub 2013 Oct 21.

Abstract

Transcatheter closure of ventricular septal defect (VSD) has been widely used worldwide. Despite high success rate and minimal operative mortality, arrhythmia during and post-operation has been frequently observed. However, sustained ventricular tachycardia following deployment of occluder has not been reported. In this present case, we present one rare case of late-onset sustained ventricular tachycardia, which developed 71 hr after deployment of an Amplatzer-type occluder for perimembranous VSD (PmVSD) in a 3-year and 5-month-old boy. The sustained ventricular tachycardia was successfully corrected with the administration of lidocaine, amiodarone, and dexamethasone. The reoccurrence of ventricular tachycardia was not observed in the most recent follow-up at 6 month. In summary, the current case indicated that sustained ventricular tachycardia could occur following deployment of Amplatzer-type occluder for PmVSD, which could be corrected with antiarrhythmic drugs.

Keywords: cath/intervention; complications pediatric; pediatric interventions; valvular heart disease.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Arrhythmia Agents / therapeutic use
  • Cardiac Catheterization / adverse effects*
  • Cardiac Catheterization / instrumentation*
  • Child, Preschool
  • Drug Therapy, Combination
  • Echocardiography, Doppler, Color
  • Electrocardiography
  • Heart Septal Defects, Ventricular / diagnosis
  • Heart Septal Defects, Ventricular / therapy*
  • Humans
  • Prosthesis Design
  • Septal Occluder Device*
  • Tachycardia, Ventricular / diagnosis
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / etiology*
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents